152 Odcinki

  1. Medical Affairs Series, Part Five: Medical Affairs in the Early Stage

    Opublikowany: 10.01.2020
  2. Real World Evidence and Rare Diseases

    Opublikowany: 20.12.2019
  3. The Digital Therapeutics Alliance: A European Perspective

    Opublikowany: 11.12.2019
  4. Medical Affairs Series, Part Four: Medical Affairs in the Field

    Opublikowany: 20.11.2019
  5. Medical Affairs Series, Part Three: Moving to the Left

    Opublikowany: 6.11.2019
  6. Advocacy Archetypes

    Opublikowany: 24.10.2019
  7. Medical Affairs Series, Part Two - Measuring the Unmeasurable: Medical Affairs Metrics

    Opublikowany: 9.10.2019
  8. Why We Resist

    Opublikowany: 25.09.2019
  9. Medical Affairs Series, Part One: A Foundation for Medical Affairs

    Opublikowany: 11.09.2019
  10. A Regulatory Roadmap for Real World Evidence

    Opublikowany: 28.08.2019
  11. Talented Teams

    Opublikowany: 14.08.2019
  12. Digital Therapeutics

    Opublikowany: 31.07.2019
  13. Talking About PIE

    Opublikowany: 17.07.2019
  14. MOAs in ONC: The Latest and Greatest in the Oncology Pipeline

    Opublikowany: 3.07.2019
  15. Episode 037: Psychology in Clinical Trials

    Opublikowany: 19.06.2019
  16. Episode 036: Commercialization for Emerging Companies

    Opublikowany: 5.06.2019
  17. Episode 035: How Translational Science Can Solve Pharma's Productivity Puzzle

    Opublikowany: 15.05.2019
  18. Episode 034: Can the Gut Microbiome Revolutionize Medical Care?

    Opublikowany: 1.05.2019
  19. APAC Edition: Medical Affairs in China

    Opublikowany: 26.04.2019
  20. Episode 033: From DTC to DT"Me" - The Future of Communications in Pharmaceuticals

    Opublikowany: 17.04.2019

6 / 8

The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.

Visit the podcast's native language site